Masters of Scale Rapid Response: How "startup DNA" helped One Medical respond to Covid, with CEO Amir Rubin
May 28, 2020
Amir Rubin, CEO of One Medical and a leader in membership-based primary care, shares how his company swiftly adapted to the COVID-19 crisis. He discusses the transition to telemedicine and the implementation of respiratory care clinics. Rubin highlights the role of reliable COVID-19 testing in ensuring safety and the innovative 'Healthy Together' program for workforce management. He emphasizes the importance of a consistent mission, allowing One Medical to thrive in changing environments and improve patient engagement through technology.
AI Snips
Chapters
Transcript
Episode notes
IPO Day
- One Medical's IPO coincided with news of a virus in China, Brexit, and a presidential impeachment.
- Despite market uncertainty, the company proceeded with the IPO.
Preparedness
- One Medical's standardized operations and national model prepared them to serve during the pandemic.
- Existing infrastructure, like lab interfaces and specimen collection, facilitated a quick response.
Improvisation and Service
- One Medical improvised early on by purchasing painter's suits from Home Depot for PPE.
- Their service-oriented culture prompted staff to offer community testing when in-office visits decreased.